Skip to main content
Premium Trial:

Request an Annual Quote

Agilent and Pierce Sign Co-Marketing Agreement for Bioanalyzer and Consumables

NEW YORK, April 8 - Agilent and Pierce Biotechnology, of Rockford, Ill., announced today a co-marketing agreement for Agilent's 2100 bioanalyzer and protein LabChip kits,  along with Pierce's protein reagents and consumables.

 

The companies said they will initially focus on protein applications where they have existing products. They will develop joint application notes showing how the bioanalyzer and LabChip kits, which measure sample quality and quantity, can be used with Pierce's samples.

 

Agilent, of Palo Alto, Calif., also said that it has sold 1,800 bioanalyzers to date.

 

Pierce is a subsidiary of Perbio Science in Stockholm, Sweden.

 

 

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.